A BioBricks® toolbox for multiplexed metabolic engineering of central carbon metabolism in the tetracenomycin pathway
Author:
Nguyen Jennifer T., Riebschleger Kennedy K., Brown Katelyn V., Gorgijevska Nina M., Nybo S. EricORCID
Abstract
ABSTRACTThe tetracenomycins are aromatic anticancer polyketides that inhibit peptide translation via binding to the large ribosomal subunit. Here, we expressed the elloramycin biosynthetic gene cluster in the heterologous host Streptomyces coelicolor M1146 to facilitate the downstream production of tetracenomycin analogs. We developed a BioBricks® genetic toolbox of genetic parts for substrate precursor engineering in S. coelicolor M1146::cos16F4iE. We cloned a series of integrating vectors based on the VWB, TG1, and SV1 integrase systems to interrogate gene expression in the chromosome. We genetically engineered three separate genetic constructs to modulate tetracenomycin biosynthesis: 1) the vhb hemoglobin from obligate aerobe Vitreoscilla stercoraria to improve oxygen utilization; (2) the accA2BE acetyl-CoA carboxylase to enhance condensation of malonyl-CoA; (3) lastly, the sco6196 acyltransferase, which is a “metabolic regulatory switch” responsible for mobilizing triacylglycerols to β-oxidation machinery for acetyl-CoA. In addition, we engineered the tcmO 8-O-methyltransferase and newly identified tcmD 12-O-methyltransferase from Amycolatopsis sp. A23 to generate tetracenomycins C and X. We also co-expressed the tcmO methyltransferase with oxygenase urdE to generate the analog 6-hydroxy-tetracenomycin C. Altogether, this system is compatible with the BioBricks® [RFC 10] cloning standard for the co-expression of multiple gene sets for metabolic engineering of Streptomyces coelicolor M1146::cos16F4iE.
Publisher
Cold Spring Harbor Laboratory
Reference45 articles.
1. The structure of tetracenomycin C;The Journal of Antibiotics,2012 2. Metabolic products of microorganisms. 225. Elloramycin, a new anthracycline-like antibiotic from Streptomyces olivaceus. Isolation, characterization, structure and biological properties. 3. Structure-activity relationships of elloramycin and tetracenomycin C. 4. Tetracenomycin X Exerts Antitumour Activity in Lung Cancer Cells through the Downregulation of Cyclin D1;Marine Drugs,2019 5. Osterman, I. A. , Wieland, M. , Maviza, T. P. , Lashkevich, K. A. , Lukianov, D. A. , Komarova, E. S. , Zakalyukina, Y. v. , Buschauer, R. , Shiriaev, D. I. , Leyn, S. A. , Zlamal, J. E. , Biryukov, M. v. , Skvortsov, D. A. , Tashlitsky, V. N. , Polshakov, V. I. , Cheng, J. , Polikanov, Y. S. , Bogdanov, A. A. , Osterman, A. L. , … Sergiev, P. v. (2020). Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel. Nature Chemical Biology, 1–7. https://doi.org/10.1038/s41589-020-0578-x
|
|